Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Compass Therapeutics
CMPX
$373M
| $1.96M | ﹤0.01% |
371,058
-39,099
| -10% | -$226K |
|
2727
Coherus Oncology
CHRS
$217M
| $1.95M | ﹤0.01% |
1,155,901
+220,662
| +24% | +$392K |
|
2728
Rezolute
RZLT
$480M
| $1.95M | ﹤0.01% |
638,384
-26,774
| -4% | -$80.4K |
|
2729
Latham Group
SWIM
$646M
| $1.95M | ﹤0.01% |
362,356
-22,126
| -6% | -$141K |
|
2730
Fresenius Medical Care
FMS
$13.2B
| $1.91M | ﹤0.01% |
84,833
+37,224
| +78% | +$855K |
|
2731
NRC Health Common Stock
NRC
$474M
| $1.91M | ﹤0.01% |
112,374
-2,593
| -2% | -$44.1K |
|
2732
Aspen Aerogels
ASPN
$387M
| $1.9M | ﹤0.01% |
556,725
+16,402
| +3% | +$55.3K |
|
2733
RLX Technology
RLX
$2.48B
| $1.9M | ﹤0.01% |
865,133
-2,964
| -0.3% | -$6.82K |
|
2734
Bumble
BMBL
$367M
| $1.9M | ﹤0.01% |
582,530
-21,213
| -4% | -$70.5K |
|
|
CTNM
2735
Contineum Therapeutics
CTNM
$526M
| $1.88M | ﹤0.01% |
144,009
+33,948
| +31% | +$455K |
|
2736
Caledonia Mining Corp
CMCL
$360M
| $1.87M | ﹤0.01% |
82,848
-18,817
| -19% | -$525K |
|
2737
RxSight
RXST
$215M
| $1.86M | ﹤0.01% |
301,622
+10,608
| +4% | +$88.1K |
|
|
NPB
2738
Northpointe Bancshares
NPB
$594M
| $1.84M | ﹤0.01% |
106,868
-5,893
| -5% | -$104K |
|
2739
Red River Bancshares
RRBI
$655M
| $1.84M | ﹤0.01% |
20,363
+6,203
| +44% | +$525K |
|
|
ESPR
2740
DELISTED
Esperion Therapeutics
ESPR
| $1.84M | ﹤0.01% |
670,285
-45,041
| -6% | -$143K |
|
|
BRCB
2741
Black Rock Coffee Bar Inc
BRCB
$170M
| $1.83M | ﹤0.01% |
141,959
-1,671
| -1% | -$27.1K |
|
2742
Kyverna Therapeutics
KYTX
$450M
| $1.82M | ﹤0.01% |
211,088
+85,662
| +68% | +$714K |
|
2743
SIGA Technologies
SIGA
$223M
| $1.82M | ﹤0.01% |
340,321
+23,620
| +7% | +$147K |
|
2744
Patria Investments
PAX
$1.72B
| $1.82M | ﹤0.01% |
144,227
-21,556
| -13% | -$303K |
|
|
LMRI
2745
Lumexa Imaging Holdings
LMRI
$1.05B
| $1.8M | ﹤0.01% |
+209,451
| New | +$2.88M |
|
2746
Hyliion Holdings
HYLN
$663M
| $1.79M | ﹤0.01% |
1,018,660
-28,694
| -3% | -$57.7K |
|
2747
Gevo
GEVO
$397M
| $1.78M | ﹤0.01% |
652,348
-12,946
| -2% | -$26.8K |
|
2748
XP
XP
$8.62B
| $1.76M | ﹤0.01% |
92,406
+5,050
| +6% | +$97.6K |
|
2749
OraSure Technologies
OSUR
$273M
| $1.76M | ﹤0.01% |
585,837
-36,246
| -6% | -$103K |
|
2750
Telos
TLS
$337M
| $1.76M | ﹤0.01% |
419,389
-20,012
| -5% | -$94.6K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.